Embecta Corp. (NASDAQ:EMBC) Q4 2025 Earnings Call Transcript

Embecta Corp. (NASDAQ:EMBC) Q4 2025 Earnings Call Transcript November 25, 2025 Embecta Corp. misses on earnings expectations.
IEEE

Development of an Artificial Pancreas with a Low-cost Insulin Pump

Abstract: This paper describes personalised, intelligent methods for designing an automated artificial pancreas (AP) to regulate type 1 diabetes blood sugar. Initial insulin-glucose regulation can be ...
drugdeliverybusiness

Modular Medical submits next-gen insulin pump to FDA, expects 2026 launch

[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance. Modular Medical’s current pump, ...
BioSpace

Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance

Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...
drugdeliverybusiness

Renu MedTech introduces tubeless insulin patch pump in India

[Image from Renu MedTech on LinkedIn] Renu MedTech today unveiled InsuPatch, its tubeless insulin patch pump designed specifically for advancing diabetes care in India. On LinkedIn, the Pune, ...